Vol 1, No 1 (2009)
Mol Cell Pharmacol
Table of Contents
PharmSights
| Working together: Farnesyl transferase inhibitors and statins block protein prenylation | Abstract PDF |
| Jonathan W. Wojtkowiak, Richard A. Gibbs, Raymond R. Mattingly | 1-6 |
| Human arylamine N-acetyltransferase 1 (NAT1) as a target of chemotherapeutic drugs in breast cancer: cisplatin as a model | Abstract PDF |
| Nilusha Ragunathan, Julien Dairou, Benjamin Pluvinage, Marta Martins, Jean-Marie Dupret, Fernando Rodrigues-Lima | 7-10 |
Research Articles
| Differentiation of cochlear neural progenitors with SV40 in vitro | Abstract PDF |
| Ling Feng, Yuki Hamajima, Masahiro Komori, John Anderson, Dong Wang, Terry C. Burns, Catherine M. Verfaillie, Walter C. Low, Jizhen Lin | 11-22 |
| Smac deficiency affects endoplasmic reticulum stress-induced apoptosis in human colon cancer cells | Abstract PDF |
| Qin He, Jingxue Shi, Samantha Jones, Jie An, Yuxin Liu, Ying Huang, M. Saeed Sheikh | 23-28 |
Reviews
| Anti-Inflammatory Agents for Cancer Therapy | Abstract PDF |
| Elizabeth R. Rayburn, Scharri J. Ezell, Ruiwen Zhang | 29-43 |
| Role of Radiation-induced TGF-beta Signaling in Cancer Therapy | Abstract PDF |
| Horatiu C. Dancea, Mohammed M. Shareef, Mansoor M. Ahmed | 44-56 |
| Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy | Abstract PDF |
| Sanjib Chowdhury, Sudhakar Ammanamanchi, Gillian M. Howell | 57-70 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.